Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches
and is the most common primary vasculitis in adults. LVV comprises two distinct conditions …

Purpose Monitoring disease activity in patients with large vessel vasculitis (LVV) can be
challenging.[18F] FDG-PET/CT is increasingly used to evaluate treatment response in LVV …

Objective To provide evidence‐based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large …

Objectives To update the EULAR recommendations for the use of imaging modalities in
primary large vessel vasculitis (LVV). Methods A systematic literature review update was …

Objective To identify and validate, using computer‐driven methods, patterns of arterial
disease in Takayasu arteritis (TAK) and giant cell arteritis (GCA). Methods Patients with TAK …

Giant cell arteritis (GCA) is the most common type of primary vasculitis in Western countries.
Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease …

Objectives Efficacy evaluation of GCA treatment is primarily based on non-specific
symptoms and laboratory markers. We aimed to assess the change in vascular inflammation …

Objectives To assess the sensitivity to change of ultrasound halo features and their
association with disease activity and glucocorticoid (GC) treatment in patients with newly …

Objective To assess whether vascular activity seen on 18F‐fluorodeoxyglucose–positron
emission tomography (FDG‐PET) scan is associated with angiographic change in large …

Giant cell arteritis (GCA) is a granulomatous systemic vasculitis of large-and medium-sized
arteries that affects the elderly. In recent years, advances in diagnostic imaging have …